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Abstract
In Alzheimer’s disease (AD) cerebrovascular function is at risk. Transcranial Doppler, near-infrared spectroscopy, and photoplethysmography
are noninvasive methods to continuously measure changes in cerebral blood flow velocity (CBFV), cerebral cortical oxygenated hemoglobin
(O2Hb), and blood pressure (BP). In 21 patients with mild to moderate AD and 20 age-matched controls, we investigated how oscillations in
erebral blood flow velocity (CBFV) and O2Hb are associated with spontaneous and induced oscillations in blood pressure (BP) at the very low
(VLF  0.05 Hz) and low frequencies (LF  0.1 Hz). We applied spectral and transfer function analysis to quantify dynamic cerebral
autoregulation and brain tissue oxygenation. In AD, cerebrovascular resistance was substantially higher (34%, AD vs. control:   0.69 (0.25)
mm Hg/cm/second, p 0.012) and the transmission of very low frequency (VLF) cerebral blood flow (CBF) oscillations into O2Hb differed, with
ncreased phase lag and gain ( phase 0.32 [0.15] rad;  gain 0.049 [0.014] mol/cm/second, p both  0.05). The altered transfer of CBF to
cortical oxygenation in AD indicates that properties of the cerebral microvasculature are changed in this disease.
© 2012 Elsevier Inc.
Keywords: Alzheimer’s disease; Cerebrovascular disease; Brain tissue oxygenation; Transcranial Doppler sonography; Near infrared spectroscopy; Cerebral
autoregulation
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In patients with Alzheimer’s disease (AD) and in mouse
models of AD, the structural integrity of the cerebral vas-
culature, especially of cortical microvessels, is markedly
compromised (Farkas and Luiten, 2001). Additionally, dy-
namic cerebral autoregulation, the vascular mechanism
which aims to stabilize brain perfusion, is impaired in
mouse models of AD (Han et al., 2008; Iadecola et al.,
2009). Whether dynamic cerebral autoregulation is also
altered in human AD remains unknown. Recently, we have
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Open access under the Elsevier OA license.shown that patients with early stage AD have a reduced
cerebral blood flow velocity (CBFV) and an increased cere-
brovascular resistance (CVR) compared with age-matched
healthy controls. Moreover, AD patients had smaller sponta-
neous cerebral blood flow (CBF) oscillations, relative to blood
pressure (BP) oscillations. This implies a reduction in transfer
function gain, a parameter that quantifies dynamic cerebral
autoregulation and describes how changes in BP are trans-
ferred to changes in CBF (Claassen et al., 2009a). Notably,
changes in CBF were measured using transcranial Doppler
(TCD) in the middle cerebral artery (MCA), reflecting
global changes in CBF but not necessarily changes that
occur at brain tissue level (van Beek et al., 2008).
Near-infrared spectroscopy (NIRS) and functional mag-
netic resonance imaging (MRI) have revealed spontaneous
oscillatory changes in cerebral cortical oxygenation (Obrig
et al., 2000). These oscillations appear similar to those
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ever, the exact characteristics of the relationship between
dynamic changes in CBFV measured in the basal cerebral
arteries and brain tissue oxygenation remains unknown. It is
possible that oscillations in brain tissue oxygenation are
induced by changes in global CBF and that the dynamic
relationship between these variables reflects not only the
function of the cerebral vasculature to deliver oxygen to the
brain tissue, but also brain tissue oxidative metabolism
(Nagata et al., 2002). We hypothesized that vascular abnor-
malities in AD may alter this dynamic relationship between
CBF and brain tissue oxygenation. In this article we focus
on the two different but dependent dynamic relationships,
the relation between BP and CBF on the one hand and the
relation between CBF and cerebral cortical oxygenation on
the other.
CBF velocity in the middle cerebral artery changes dra-
matically if large changes in BP are induced by changes in
body posture from sitting or squatting to upright standing
(Claassen et al., 2009b; van Beek et al., 2010). This pro-
vides a model to study not only the relationship between BP
and CBF, but also between CBF and cerebral cortical oxy-
genation. The aim of this study was to test the hypothesis
that oscillations in BP and CBF, associated with changes in
body posture, are transmitted into changes in brain cortical
oxygenation and that this dynamic relationship is altered in
patients with mild to moderate AD.
For this purpose, beat-to-beat changes in BP, CBF ve-
locity, and concentrations of frontal cortical oxyhemoglobin
(O2Hb) and deoxyhemoglobin (HHb) were measured con-
tinuously using finger arterial blood pressure measurements,
TCD, and NIRS, during repeated sit-stand maneuvers in
patients with newly diagnosed AD. Fourier spectral and
transfer function analysis were used to quantify the magni-
tude of oscillations and the dynamic relations between these
variables. The repeated sit-stand maneuvers were performed
to augment the spontaneous BP and CBFV oscillations (van
Beek et al., 2010). They induce large oscillations in BP,
CBFV, and O2Hb and enhance the coherence between these
ariables (0.4) and therefore improve the reliability of the
ransfer function analysis (van Beek et al., 2008). The re-
eated sit-stand maneuvers were performed at 0.05 and 0.1
z. At the very low frequency (0.05 Hz) dynamic cerebral
utoregulation is active, but in the low frequency (0.1 Hz)
ynamic cerebral autoregulation is less active (Zhang et al.,
998).
. Methods
.1. Subjects
We recruited 21 AD patients, aged 65 years and older.
ll patients had been newly diagnosed with AD in the
emory clinic at Radboud University Nijmegen Medical
entre. Patients were diagnosed with mild or moderate AD
ccording to the criteria of the National Institute of Neuro-ogical and Communicative Disorders and Stroke and the
lzheimer’s Disease and Related Disorders Association
NINCDS-ADRDA), Clinical Dementia Rating (CDR)
.5–2 (McKhann et al., 1984). They were not yet treated
ith cholinesterase inhibitors. As a control group, 20 age-
atched healthy old persons were selected from a group of
olunteers that responded to a newspaper advertisement. All
atients and volunteers were carefully examined by a geri-
trician, including physical examination, laboratory evalu-
tion, computerized tomography (CT) (n  2) or MRI scan
n  39) of the brain, and neuropsychological testing. All
ontrols and randomly selected patients (n  10), under-
ent a Doppler study of the carotid and vertebral arteries to
ule out significant stenosis (50%).
The study was approved by the Ethics Committee for
esearch on Human Subjects, Radboud University Nijme-
en Medical Centre, and all volunteers and primary care-
ivers of the AD patients gave written informed consent,
nd AD patients themselves gave verbal consent.
.2. CBFV and NIRS measurements
Using TCD, CBFV was measured in the MCA. Changes
n CBFV represent changes in flow, under the assumption
hat the diameter of the insonated vessel remains constant.
he MCA is 1 of the major conduit arteries of the cerebral
irculation and branches directly from the common carotid
rtery. Many studies have demonstrated that the diameter of
he MCA does not change appreciably even during moder-
te alterations in BP and end-tidal CO2 (Giller et al., 1993;
Newell et al., 1994; Serrador et al., 2000). Therefore,
changes in CBFV should represent predominately changes
in CBF in this study. Further, it was assumed that there is no
displacement of the MCA with respect to the probe position
during repetitive vertical postural changes (Claassen et al.,
2009b).
NIRS measures cerebral cortical changes in O2Hb and
HHb. The basic principle of NIRS is that near-infrared light
penetrates the skull and brain, and is absorbed by the chro-
mophores O2Hb and HHb, that have different absorption
spectra. Assuming constant scattering, changes in concen-
tration of these chromophores can be deduced, using the
modified Lambert-Beer Law (Claassen et al., 2006; Rowley
et al., 2007). The measurements lump all hemoglobin con-
centration change from a volume of brain under the optodes.
This volume might include all types of vessels. However,
the actual vessel volume within the examined tissue is very
small, and contribution of hemoglobin in conduit vessels to
the NIRS signal are negligible. Total hemoglobin (THb), the
sum of O2Hb and HHb, is associated with local cerebral
blood volume, whereas O2Hb is associated with local cere-
bral blood flow (Reinhard et al., 2006).
We applied a continuous wave NIRS device with 3 light
bundles with wavelengths of 775 nm, 845 nm, and 904 nm
(Oxymon, Artinis Medical Systems™, Zetten, the Nether-
lands). A fixed differential path length factor (DPF) of 6.6
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accounts for the increased distance traveled by light due to
scattering (Claassen et al., 2006). At present, no data are
available on the actual variation of the DPF with age above
50 years. Our control and patient group, however, were
age-matched, which should reduce any systemic measure-
ment bias induced by using a fixed DPF.
2.3. Data acquisition
Subjects were in sitting position and received first a
3-lead electrocardiogram (ECG) for measurement of the
interval between consecutive R-peaks (RR interval). BP
was measured using a photoplethysmography cuff on the
index or middle finger of the left hand (Finometer, Finapres
Medical Systems, Amsterdam, the Netherlands), with the
hand resting approximately at heart level supported by a
sling. Data were collected by the Finometer (Finapres Med-
ical Systems) for an uninterrupted period which lasted for a
maximum of 5 minutes. Transcranial Doppler ultrasonog-
raphy was used to measure CBFV. The left and right middle
cerebral artery were insonated by placing a 2-MHz Doppler
probe (Multi-Dop, Compumedics DWL, Singen, Germany)
over the temporal window. The middle cerebral arteries
were identified according to their signal depth, velocity, and
wave characteristics (Aaslid et al., 1982). If only 1 signal
was available due to 1-sided temporal window failure, we
included this available signal for analysis. The probes were
locked at a constant angle and position during data collec-
tion with a customized headband (Spencer Technologies,
Seattle, WA, USA). Two pairs of NIRS optodes were placed
and tightly fixed over the left and right frontal cortex in the
same headband that locked the Doppler probes. The mid-
point between the horizontally positioned pairs was Fp1 for
the left pair and Fp2 for the right pair, according to the
international 10–20 electrode system. An interoptode dis-
tance of 5.0 cm was used to minimize contamination from
the extracerebral circulation and to maximize the signal
intensity (Claassen et al., 2006). NIRS cables and optodes
were tightly fixed to prevent movement artifacts. Arterial
saturation (SaO2) was recorded with a pulse oxymeter and
end tidal CO2 (EtCO2) using a capnograph (N1000, Nellcor,
oulder, CO, USA). All data were sampled at 125 Hz.
.4. Protocol
From 12 hours before the study, subjects refrained
rom caffeinated beverages and alcohol. They had a light
reakfast at least 2 hours before the visit. All experiments
ere performed in the morning, in a quiet environmen-
ally-controlled laboratory. After at least 30 minutes of
itting rest, spontaneous oscillations data were collected
or 5 minutes. To assess the dynamic pressure flow as
ell as the flow-brain tissue oxygenation relationship,
pontaneous BP and CBFV oscillations were augmented
sing repeated sit-stand maneuvers at 2 different frequen-
ies (van Beek et al., 2010). Subjects were instructed toerform repeated sit-stand maneuvers at 0.05 Hz (10-
econd sit followed by 10-second stand) for 5 minutes
nd at 0.1 Hz (5-second sit followed by 5-second stand)
or 4 minutes. Verbal signs were given to facilitate re-
eated changes in body posture. The maneuvers were
eparated by 10 minutes for recovery.
.5. Data processing
All data were simultaneously recorded for offline analy-
is (Oxysoft, Artinis Medical Systems). A running average
lter of 1 seconds was applied to the O2Hb and HHb signals
to increase the signal-to-noise ratio, and to reduce the heart
beat and high frequency noise (Claassen et al., 2006; Row-
ley et al., 2007).
Spectral analysis was performed on beat-to-beat mean
BP, CBFV, O2Hb, and HHb changes. The signals were
aligned with the time of the R wave peaks of the electro-
cardiogram (ECG). The time series were then linearly in-
terpolated at 2 Hz to obtain equidistant time intervals and
detrended with third-order polynomial fitting. These data
then were subdivided into 128 segments with 50% overlap
and a Hanning window was applied for spectral estimation.
These data segmentations are based on a trade-off between
a reduction in spectral variance and keeping sufficient spec-
tral resolution. Each Hanning-windowed segment was fast-
Fourier transformed and the periodograms were averaged to
calculate the autospectrum of BP, CBFV, O2Hb, and HHb
Zhang et al., 1998).
For spectral analysis the following frequency ranges
ere chosen: the very low frequency (VLF) range: 0.02–
.07 Hz for spontaneous oscillations and for the induced
.05-Hz maneuver, and the low frequency (LF) range:
.07– 0.13 Hz for spontaneous oscillations and for the
.1-Hz maneuver (van Beek et al., 2010). Spectral power
f oscillations was calculated as area under the curve
AUC) of the power spectral density plots. For compar-
sons, power spectral density plots of BP, CBFV, O2Hb,
and HHb were included if data on all signals were avail-
able for sitting rest and during both repeated sit-stand
maneuvers.
The dynamic relation between BP as input and CBFV
as output (BP-CBFV) and the dynamic relation between
CBFV as input and O2Hb as output (CBFV-O2Hb) were
determined with transfer function analysis during the
repeated sit-stand maneuvers. Because of low coherence,
we did not include the calculation of transfer function
during spontaneous oscillations of the above dynamic
relationships and between CBFV as input and HHb as
output (CBFV-HHb) during spontaneous and induced
oscillations. Mean values of phase, gain, and coherence
of the transfer function were analyzed in the same VLF
and LF as described above. We have previously de-
scribed the explanation of these estimates in detail
(Claassen et al., 2009b; van Beek et al., 2008, 2010). In
short, the phase shift quantifies the displacement in time
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determines the magnitude relationship between 2 signals.
Coherence tests the linearity of the relationship between
these signals. Coherence approaching unity in a specific
frequency suggests a linear relationship, whereas coher-
ence approaching 0 indicates no relationship between the
signals, severe extraneous noise, or a nonlinear relation-
ship (Giller and Mueller, 2003). A coherence of 0.4 is
considered the lower limit where transfer function esti-
mates can be calculated with confidence (Zhang et al.,
1998). Estimates of phase, gain, and coherence were
therefore only included if coherence was 0.4 (Table 1).
All analyses were performed with commercially avail-
able software (DADiSP, version 6.0, DSP Development,
Cambridge, MA, USA).
2.6. Statistical analysis
Data are presented as mean  SD. Normal distribution
as tested using Q-Q plots and could not be assumed for
ower spectral data of beat-to-beat mean BP, CBFV, O2Hb,
and HHb. Comparisons between the control and patient
group were made using the independent samples t test and
the Mann-Whitney U test. For the comparisons of the trans-
fer function estimates between both 0.05 Hz and 0.1 Hz
maneuvers a paired samples t test was applied. Statistical
Table 1
Hemodynamics in Healthy Controls and Alzheimer’s Patients During 2 R
Healthy controls
0.05 Hz
umber of subjectsa 16
HR (bpm) 68.18 (7.3)
BP (mm Hg) 91.27 (14.7)
BFV (cm/s) 46.43 (7.9)
etCO2 (mm Hg) 34.23 (2.5)
S BP (mm Hg2) 42.89 (19.1)
PS CBFV ((cm/s)2) 17.28 (9.8)
S oxyHb ((mol/L)2) 0.15 (0.08)
S HHb ((mol/L)2) 0.10 (0.09)
FA BP-CBFVd
Number of subjects 16
Phase (rad) 0.73 (0.29)
Gain (cm/s/mm Hg) 0.55 (0.16)
nGain (% cm/s/% mm Hg) 1.18 (0.29)
Coherence 0.65 (0.12)
FA CBFV-oxyHb
Number of subjects 15
Phase (rad) 0.81 (0.29)
Gain (cm/s/mm Hg) 0.076 (0.021)
Coherence 0.53 (0.086)
verage of 5 and 4 minutes repeated sit-stand at 0.05 Hz and at 0.1 Hz, re
ere included for analysis. Values are presented as mean, with standard d
BFV.
ey: BP, blood pressure; bpm, beats per minute; CBFV, cerebral blood fl
ain; oxyHb, oxygenated hemoglobin; PetCO2, pressure of end-tidal CO2
a Data were only included if measurements on all signals were availabl
b p  0.01.
c p  0.05, compared with healthy control in the same frequency range
d Data were only included if coherence of the transfer function was 0significance was set at p 0.05. All statistical analysis were aerformed using statistical software (SPSS version 16.0,
PSS, Inc, Chicago, IL, USA).
. Results
.1. Baseline characteristics
Table 2 presents the baseline characteristics of patients
nd controls at screening. Patients and controls were
atched for age and blood pressure level at screening (Ta-
le 2). Specifically, 15 out of 21 AD patients and 14 out of
0 controls were hypertensive (BP 140/90) at screening.
ore AD patients however, used antihypertensive medica-
ion (12 vs. 4) and 5 AD patients had diabetes mellitus type
. As expected, patients had substantially lower cognitive
ests scores and more hippocampal atrophy. The difference
n age-related white matter score was not significant ( 1.9
n the 30-point scale, p  0.089).
.2. Baseline hemodynamic measurements
Table 3 provides an overview of the baseline hemody-
amics under resting conditions. Heart rate (HR) and BP
ata could be obtained in all controls and patients. In 1
ontrol and 4 AD patients, data on CBFV could not be
btained due to an insufficient temporal window. Addition-
Sit-Stand Maneuvers
Alzheimer’s patients
Hz 0.05 Hz 0.1 Hz
15 15
.50 (7.0) 79.21 (13.5)b 85.45 (14.5)b
.05 (13.5) 105.64 (21.1)c 104.84 (21.5)
.45 (7.5) 40.79 (14.8) 43.53 (14.8)
.24 (2.2) 34.01 (2.7) 33.8 (2.4)
.24 (7.19) 38.36 (26.0) 17.49 (13.8)
.63 (4.2) 18.72 (17.7) 8.24 (5.8)
58 (0.047) 0.29 (0.2) 0.11 (0.16)
36 (0.043) 0.12 (0.09) 0.043 (0.054)
13 15
.70 (0.23) 0.81 (0.24) 0.65 (0.21)
.60 (0.13) 0.47 (0.17) 0.62 (0.22)
.36 (0.25) 1.25 (0.30) 1.43 (0.31)
.76 (0.13) 0.68 (0.11) 0.77 (0.10)
10 10
.14 (0.67) 1.13 (0.44)c 1.11 (0.57)
84 (0.05) 0.13 (0.049)c 0.078 (0.020)
.60 (0.10) 0.60 (0.13) 0.57 (0.11)
ely. For CBFV either the average of left and right, or the available signal
n in parentheses. PS BP and PS CBFV denote spectral power of BP and
city; HHb, deoxygenated hemoglobin; HR, heart rate; nGain, normalized
wer spectrum; TFA, transfer function analyses.epeated
0.1
17
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46
34
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7
0.0
0.0
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0
0
1
0
16
1
0.0
0
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systolic and diastolic BP (sphygmomanometry) were com-
parable between AD and controls at screening, mean arterial
pressure as obtained from the average of 5 minutes record-
ing at rest using Finometer was higher in AD. Moreover,
resting heart rate and spontaneous BP oscillations at the LF
range of 0.1 Hz were higher in AD.
In patients with AD, despite the higher BP, CBFV was
reduced by 10% compared with controls. Consistently, there
was a 34% increase in cerebrovascular resistance index in
AD (difference  0.69 [0.25] mm Hg/cm/second, p 
0.012) (Table 3). Alzheimer patients also had larger spon-
taneous oscillations in CBFV and O2Hb at the LF range
Table 3).
.3. Repeated sit-stand maneuvers
Representative changes in BP, CBFV, and O2Hb and
HHb during baseline, and the 0.05 Hz and 0.1 Hz sit-stand
maneuvers, are presented in Fig. 1. Note that, as expected,
O2Hb and HHb oscillate in counterphase, and further that
Table 2
Baseline Characteristics of Healthy Controls and Alzheimer’s Patients
Healthy controls Alzheimer’s patients
ge (years) 74.5 (2.8) 72.3 (5.7)
ender (male:female) 14:6 9:12
MI 24.8 (2.5) 24.5 (3.1)
P sys (mm Hg) 148.3 (20.0) 150.5 (18.9)
P dias (mm Hg) 83.3 (8.9) 80.1 (9.7)
DR (range) 0 1.0 (0.5–2.0)
MSE 29.3 (1.2) 21.3 (4.7)a
CamCog NA 67.4 (13.4)
se of antihypertensive
medication
n  4 n  12b
Antihypertensive medication
Diuretic 3 5
ACE inhibitor — 4
CA-channel Blocker — 2
eta blocker 2 7
AT II antagonist — 1
moking n  3 n  2
Diabetes (type 2) n  0 n  5b
MRI
MTA 0.44 (0.61) 2.00 (0.80)a
ARWMC 3.35 (3.12) 5.25 (3.09)
alues are presented as mean, with standard deviation in parentheses; CDR
s presented as mean and range because the score is an ordinal value. BP
as measured with sphygmomanometry at screening. MTA score (Schel-
ens P et al., JNNP 1992), range 0–4; ARWMC score (Wahlund LO et al.,
troke 2001), range 0–30.
ey: ACE, angiotenstin converting enzyme; ARWMC, age-related white
atter changes; AT II, angiotensin II; BMI, body mass index calculated as
eight (kg) divided by height (m2); BP, blood pressure; CA, calcium;
amCog, cognitive and self-contained part of the Cambridge Examination
or Mental Disorders of the Elderly; CDR, clinical dementia rating; dias,
iastolic; MMSE, Mini Mental State Examination; MRI, magnetic reso-
ance imaging; MTA medial temporal lobe atrophy; NA, not applicable;
ys, systolic.
a p  0.001.
b p  0.05.these oscillations appear clearly related to the oscillations inBP and CBFV. Fig. 2 shows the group averaged power
spectra of controls and AD. The repeated sit-stand maneuvers
induced oscillations in all signals (BP, CBFV, O2Hb, and
HHb), and the spectral power of these oscillations was signif-
icantly larger than for spontaneous oscillations in the corre-
sponding frequency range (Fig. 2). Notably, the 0.05 Hz re-
peated maneuver induced the most powerful oscillations.
Power spectra for BP, CBFV, O2Hb, and HHb were similar in
AD and controls in the VLF and LF range (Table 1).
Fig. 3 provides an example of the relation between the
oscillations in BP and CBFV, and of the oscillations be-
tween CBFV and O2Hb during 0.05-Hz sit-stand maneu-
vers. During this maneuver, oscillations in CBFV led those
of BP (phase lead), whereas oscillations in O2Hb follow
hose of CBFV (phase lag), suggesting a time delay between
hanges in CBF and brain tissue oxygenation.
No differences in transfer function gain and phase be-
ween BP and CBFV were observed between controls and
D (Table 1). Transfer function gain between CBFV and
2Hb was higher in AD during the 0.05 Hz repeated sit-
stand maneuver, and the phase lag between CBFV and
O2Hb was larger (Table 1 and Fig. 4). The use of antihy-
ertensive medication in the control and AD group did not
ead to within-group differences in gain and phase between
BFV and O2Hb (p all  0.1). The within-group differ-
ences for diabetes in the AD group could not be assessed,
because 3 diabetic patients were excluded from transfer
function analysis due to low coherence (that is, ultimately,
Table 3
Baseline Hemodynamics in Healthy Controls and Alzheimer’s Patients
Healthy controls Alzheimer’s patients
ean HR (bpm) 61.3 (5.8) 69.7 (11.8)a
Mean BP (mm Hg) 78.8 (10.4) 87.6 (18.8)a
Mean CBFV (cm/s) 42.1 (9.9) 37.7 (14.7)
CVRi (mm Hg/cm/s) 2.00 (0.55) 2.68 (0.97)a
PetCO2 (mm Hg) 34.7 (3.1) 35.2 (2.5)
P VLF (mm Hg2) 4.62 (1.8) 7.42 (4.8)
P LF (mm Hg2) 1.19 (0.6) 2.29 (1.8)a
CBFV VLF ((cm/s)2) 2.43 (1.3) 3.49 (1.3)
BFV LF ((cm/s)2) 0.55 (0.3) 1.29 (1.0)a
oxyHb VLF ((mol/L)2) .038 (0.012) 0.084 (0.1)
xyHb LF ((mol/L)2) 0.0091 (0.006) 0.037 (0.08)a
HHb VLF ((mol/L)2) 0.016 (0.009) 0.036 (0.05)
Hb LF ((mol/L)2) 0.0036 (0.003) 0.011 (0.02)
verage of 5 minutes measurement during sitting rest. For CBFV either the
verage of left and right, or the available signal were included for analysis.
alues are presented as mean, with standard deviation in parentheses.
xyHb and HHb denote changes in concentration of frontal cortical oxy-
enated and deoxygenated hemoglobin, respectively. BP VLF, BP LF,
BFV VLF, CBFV LF, oxyHb VLF, oxyHb LF, HHb VLF, and HHb LF,
pectral power of BP, CBFV, oxyHb and HHb in the very low frequency
nd low frequency range (VLF, 0.02–0.07 Hz; LF, 0.07–0.13 Hz).
ey: BP, blood pressure; CBFV, cerebral blood flow velocity; CVRi,
erebrovascular resistance index (mean BP/CBFV); HHb, deoxygenated
emoglobin; HR, heart rate; LF, low frequency; oxyHb, oxygenated he-
oglobin; PetCO , pressure of end-tidal CO ; VLF, very low frequency.2 2
a p  0.05.
ency of
428.e26 A.H.E.A. van Beek et al. / Neurobiology of Aging 33 (2012) 428.e21–428.e31only 2 patients with [type 2] diabetes were included in the
AD group for this part of the analysis).
4. Discussion
This study assessed dynamic cerebral autoregulation in
patients with Alzheimer’s disease by means of the concom-
itant registration of changes in blood pressure, blood flow
velocity in the middle cerebral artery, and cerebral frontal
cortical oxygenation. There are 3 main findings in this
study. First, in view of the fact that the origin of very low
frequency oscillations in cortical oxygenation remains dis-
puted, these data demonstrate that these oscillations are
related to changes in global CBF, as measured in the middle
cerebral artery, and that these CBF changes in turn were
related to changes in systemic blood pressure. Second, this
study shows that by using repeated sit-stand maneuvers, the
dynamic CBF-brain tissue oxygenation relation can be as-
Fig. 1. Example of blood pressure, cerebral blood flow velocity, and cortica
the 0.05 Hz and 0.1 Hz repeated sit-stand maneuvers in 1 subject. Beat-to-
blood flow velocity (CBFV; middle panel) in the left middle cerebral artery
and HHb, dashed line — both bottom panel), during baseline measurements
panel) and 0.1 Hz (right panel). Note the enhanced amplitude and consistsessed using transfer function analysis with a high coher-ence function (0.4) between these variables. Third, we
have shown that how changes in CBF are transmitted to
changes in brain tissue oxygenation differs essentially be-
tween patients with Alzheimer disease and controls, as ev-
idenced by increased transfer function gain and phase at
0.05 Hz between changes in CBF velocity and cortical
O2Hb signal.
4.1. Oscillations in cerebral and systemic hemodynamics
The NIRS method directly assesses cerebral cortical
oxygenation changes at the cerebral cortical tissue level.
In accordance with the literature, we detected spontane-
ous oscillations in O2Hb and HHb in the very low and
low frequency range, where also spontaneous variability
in BP and CBFV can be found (Obrig et al., 2000;
Schroeter et al., 2004). Compared with healthy controls,
AD patients had enhanced spontaneous oscillations in BP
l oxy- and deoxygenated hemoglobin oscillations in sitting rest and during
ta from 1 subject, variability in blood pressure (BP; upper panel), cerebral
ntal cortical oxygenated and deoxygenated hemoglobin (O2Hb, solid line,
ng rest (left panel) and the repeated sit-stand maneuvers at 0.05 Hz (middle
the oscillations induced by the 0.05 Hz repeated sit-stand maneuvers.l fronta
beat da
, left fro
in sittiin the low frequency range (around 0.1 Hz), which led to
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ut not HHb.
The repeated sit-stand maneuvers induced large oscilla-
ions in O2Hb that mirrored those in BP and CBFV. Thus
ar, only 1 study has succeeded in inducing oscillatory
2Hb changes, using deep breathing at 0.1 Hz, and these
authors observed similar oscillations in BP, CBFV, and
O2Hb (Reinhard et al., 2006). With a repeated sit-stand
maneuver, we were able to induce oscillatory O2Hb changes
in the very low frequency of 0.05 Hz, which would not have
been possible with deep breathing. Our data indicate that
oscillatory O2Hb changes in this frequency range are related
o the oscillations in CBFV, which in turn are induced by
scillations in systemic BP. The larger oscillations in BP
Fig. 2. Group averaged power spectra of blood pressure, cerebral blood fl
in sitting rest and during repeated sit-stand maneuvers. Results of spectral a
middle panel), and frontal cortical oxygenated and deoxygenated hemoglo
rest (left), the 0.05 Hz repeated sit-stand maneuver (middle), and the 0.1 H
oscillations in healthy controls, the dotted lines are for the Alzheimer’s pnd CBFV at 0.05 compared with 0.1 Hz during repeatedit-stand maneuvers are in agreement with previous studies
Claassen et al., 2009b; Hamner et al., 2004; van Beek et al.,
010). Taken together, the relationship between BP, CBFV,
nd O2Hb during repeated sit-stand maneuvers lends sup-
ort to the notion that upstream oscillations in CBF induced
y changes in BP contribute importantly to the downstream
rain tissue level oscillations in O2Hb.
4.2. CBFV and dynamic autoregulation
Confirming previous results from a pilot study measuring
only CBFV, we observed that CBFV was reduced and
cerebrovascular resistance was increased in AD (Claassen et
al., 2009a). This may be explained by enhanced vasocon-
city, and cortical frontal oxy- and deoxygenated hemoglobin oscillations
of blood pressure (BP; upper panel), cerebral blood flow velocity (CBFV;
2Hb, black line, and HHb, gray line — both bottom panel) during sitting
ted sit-stand maneuver (right). The solid lines represent the spectra of theow velo
nalysis
bin (O
z repeastriction and other vascular factors such as a reduced cere-
t
2
t
a
T as clear
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al., 2005).
We have previously shown that this difference could not
be explained by differences in individual whole brain vol-
ume (Claassen et al., 2009a). We could however not repro-
duce the earlier findings of a lower gain between BP-CBFV
during either the 0.05 Hz or 0.1 Hz repeated maneuver in
AD relative to controls. An important difference between
these studies is that in the present study patients were not
treated yet with cholinesterase inhibitors. These drugs poten-
tially alter cerebral hemodynamics (Claassen et al., 2009c).
Moreover, AD patients in the present study were older.
The CBF response to transient changes in BP, as quan-
tified by transfer function gain and phase, reflects dynamic
cerebral autoregulation (Zhang et al., 1998). The mecha-
nisms underlying dynamic autoregulation are not clear. The
unaltered gain and phase between BP and CBFV observed
in this study suggest that dynamic autoregulation — at least
at the macrovascular level — is preserved in patients with
AD. However, dynamic cerebral autoregulation was im-
paired in the mouse models of AD related to beta amyloid
Fig. 3. Example of the relation between BP and CBFV, and CBFV and
Representative data from 1 healthy control is shown. The left panel pre
hemoglobin (O2Hb; bottom panel) changes during the 0.05-Hz maneuve
represents changes in CBFV (upper and bottom panel) and the dotted line
he data at 0.1 Hz are not shown because oscillations in O2Hb were notpathology (Han et al., 2008; Iadecola et al., 2009). Thesediscrepancies may highlight the differences in the regulation
of cerebral hemodynamics between patients with AD and
the animal model used. Clearly, further work is needed to
understand the regulation of CBF and its relation to AD
pathology.
4.3. The dynamic CBFV-O2Hb relationship
The dynamic relation between oscillations in CBFV and
cortical O2Hb may reflect a regulatory mechanism to main-
ain brain tissue oxygenation homeostasis (Iadecola et al.,
009; Rowley et al., 2007). However, the investigation of
he relationship between spontaneous oscillations in CBFV
nd O2Hb using transfer function analysis suffers from the
weakness and nonstationarity of the O2Hb measurement
under resting conditions (Rowley et al., 2007). The repeated
sit-stand maneuvers in this study induced large oscillations
in BP, CBFV, and O2Hb and enhanced coherence between
CBFV-O2Hb (0.4) and therefore improve the reliability of
the transfer function analysis (van Beek et al., 2008).
CBFV was measured in the MCA. NIRS measurement
nated hemoglobin, during the repeated sit-stand maneuvers at 0.05 Hz.
e BP and CBFV changes (upper panel) and the CBFV and oxygenated
solid line represents changes in BP (upper panel), the long dashed line
s in O2Hb. Note that CBFV leads BP, whereas O2Hb lags behind CBFV.
as at 0.05 Hz.oxyge
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artery (ACA) as well as the MCA. We assumed that relative
change of CBFV in the MCA would be the same for the
relative change of CBFV in the ACA in response to a
change in blood pressure.
O2Hb oscillations seem to follow those of CBFV (Fig.
3). Therefore, the phase difference between these vari-
ables may reflect a transit time between flow in supplying
brain arteries and O2Hb. In patients with AD, a disease in
hich it becomes progressively clear that the cerebral
icrovasculature is affected, we identified a larger phase
ag and higher gain between CBFV and O2Hb at the very
ow frequency of 0.05 Hz — where dynamic cerebral
utoregulation is active — but not in the low frequency
0.1 Hz) — where autoregulation is less active (Zhang et
l., 2009). Because O2Hb is a correlate of local blood
ow, this might point to a differential transfer of central
lood flow to local blood flow and to local cerebral
xygenation in Alzheimer’s disease. Whether this is due
o differences in active regulation mechanisms or due to
ifferences in the passive properties of the cerebral vas-
ulature is not clear (Mandeville et al., 1999). The in-
Fig. 4. Transfer function analysis of cerebral blood flow velocity and
oxygenated hemoglobin in the frontal cortex in healthy controls and Alz-
heimer patients. Values of transfer function analysis between cerebral
blood flow velocity and oxygenated hemoglobin in healthy controls (CO)
and Alzheimer patients (AD) in the very low (0.02–0.07 Hz) and low
(0.07–0.13 Hz) frequency range expressed in phase (upper panel), gain
(middle panel), and coherence (bottom panel). Data of controls are pre-
sented left and of Alzheimer’s patients right. The box plots represents
group average values with the 95% confidence interval. * p  0.05
ompared with healthy controls.reases in the transfer function gain between CBFV and2Hb provide further insights into the cerebral microvas-
ular function in AD. Using positron emission tomogra-
hy (PET), it has been shown that the oxygen extraction
raction, regarded as an indicator of the brain tissue
etabolic reserve, was increased in AD (a reduction of
etabolic reserve) (Nagata et al., 2002). In addition,
educed brain metabolic rate for glucose and oxygen has
een observed in AD which may reduce the oxygen
iffusion gradient from the capillaries to brain tissue.
herefore, the increase in CBFV-O2Hb gain might also
eflect a reduced metabolic reserve or a reduced diffusion
f oxygen leading to enhanced oscillations in O2Hb in
esponse to changes in CBF.
The specific mechanisms for the altered CBFV-O2Hb
relationship in AD cannot be determined in this study.
Amyloid beta, the peptide linked to the pathological mani-
festations in AD, causes cerebrovascular dysfunction (Han
et al., 2008) as well as deposits in the small vessels in AD
(cerebral amyloid angiopathy). In turn, the brain microcir-
culation not only responds to amyloid beta, but also regu-
lates amyloid beta (Zlokovic et al., 2000). It is possible that
these abnormalities may contribute to the altered CBFV-
O2Hb relation. Further, the enhanced oscillations of O2Hb
in response to changes in CBF may lead to local hypoxic
changes in the brain that in turn could establish a vicious
circle: over expression of transcription factors in smooth
muscle cells of small brain arteries promote a hypercontrac-
tile phenotype of cerebral arteries, which may increase the
cerebrovascular resistance (CVR), and in turn leads to hyp-
oxia (Chow et al., 2007).
4.4. Study limitations
During screening, controls and patients were matched
for blood pressure. Significantly more patients used an-
tihypertensive drugs. However, cerebral autoregulation
and cerebral blood flow are preserved during treatment
with -blockers, calcium channel blockers, angiotensin-
converting enzyme inhibitors, AT1-recepter blockers, or
hiazide diuretics (Estrup et al., 2001; Heinke et al., 2005;
ipsitz et al., 2000; Pandita-Gunawardena and Clarke,
999; Zhang et al., 2007).
In the AD group, 5 subjects suffered from type 2 diabe-
es. Data regarding the influence of diabetes on cerebral
utoregulation are mixed, reporting either an impairment or
reservation of cerebral autoregulation (Brown et al., 2008;
im et al., 2008; Marthol et al., 2007). For the analysis of
he relation between CBFV-O2Hb at 0.05 Hz — where the
current study demonstrated an altered relationship in AD —
only 2 diabetic AD patients were included. This makes a
confounding effect of diabetes on our findings very un-
likely. Moreover, hypertension and diabetes mellitus are the
most important vascular risk factors for AD (Viswanathan
et al., 2009), and exclusion of AD patients with such co-
morbidities from studies would seriously hamper their gen-
eralizability.
428.e30 A.H.E.A. van Beek et al. / Neurobiology of Aging 33 (2012) 428.e21–428.e31Both methods to assess cerebral perfusion, TCD and
NIRS, have certain limitations that have been well described
in the literature and are summarized in the Methods section.
We combined these 2 measurements to provide information
on both global cerebral perfusion and brain tissue level
oxygenation in patients with AD.
4.5. Conclusion
Using a unique combination of Finapres, TCD, and
NIRS measurements, we have shown that oscillations in
cerebral blood flow velocity, induced by repeated changes
in body posture, translated into large oscillations in cerebral
cortical oxygenation. Furthermore, the dynamic relation be-
tween cerebral blood flow velocity and cerebral cortical
oxygenation can be assessed using transfer function analysis
during repeated sit-stand maneuvers. Finally, we demon-
strated that Alzheimer patients differed from controls in
how these changes in flow were transmitted to changes in
cerebral cortical oxygenation. This result might be indica-
tive of either altered properties of the cerebral microvascu-
lature or brain tissue oxidative metabolism in patients with
Alzheimer disease.
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